Quality-of-life assessment in the symptom management trials of the National Cancer Institute-Supported Community Clinical Oncology Program

Journal of Clinical Oncology

Volumn 23, Issue 3, 2005, Pages 591-598

  Buchanan, David R ^a   O'Mara, Ann M ^a   Kelaghan, Joseph W ^a   Minasian, Lori M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER THERAPY; CONCEPTUAL FRAMEWORK; CONTROLLED STUDY; FUNCTIONAL ASSESSMENT; HEALTH CARE ORGANIZATION; HUMAN; INTERVENTION STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; SYMPTOMATOLOGY; BIOASSAY; CLINICAL TRIAL; EVALUATION; INFORMATION PROCESSING; MULTICENTER STUDY; NEOPLASM; ONCOLOGY; PROSPECTIVE STUDY; STATISTICS; UNITED STATES;

CLINICAL TRIALS; DATA COLLECTION; ENDPOINT DETERMINATION; HUMANS; MEDICAL ONCOLOGY; MULTICENTER STUDIES; NATIONAL INSTITUTES OF HEALTH (U.S.); NEOPLASMS; PROSPECTIVE STUDIES; QUALITY OF LIFE; UNITED STATES;

EID: 14544302234     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.12.181     Document Type: Article

References (26)

1. American Society of Clinical Oncology: Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 14:671-679, 1996
2. Johnson J, Temple R: Food and Drug Administration requirements for approval of new anticancer drugs. Cancer Treat Rep 69:1155-1157, 1985
3. Soni MK, Cella D: Quality of life and symptom measures in oncology: An overview. Am J Manag Care 8:S560-S573, 2002 (suppl 18)
4. Sloan JA, Cella D, Frost M, et al: Assessing clinical significance in measuring oncology patient quality of life: Introduction to the symposium, content overview, and definition of terms. Mayo Clin Proc 77:367-370, 2002
5. Cella D, Chang C, Lai J, et al: Advances in quality of life measurement in oncology patients. Semin Oncol 29:60-68, 2002
6. Gotay C: Trial-related quality of life: Using quality of life assessment to distinguish among cancer therapies. J Natl Cancer Inst Monogr 20:1-6, 1996
7. Efficace F, Bottomley A: Do quality-of-life randomized clinical trials support clinicians in their decision-making? J Clin Oncol 20:4126-4127, 2002
8. Levine M, Ganz P: Beyond the development of quality-of-life instruments: Where do we go from here? J Clin Oncol 20:2215-2216, 2002
9. Moinpour C: Do quality of life assessments make a difference in the evaluation of cancer treatments? Control Clin Trials 18:311-317, 1997
10. Goodwin P, Black J, Bordeleau L, et al: Health-related quality-of-life measurement in randomized clinical trials in breast cancer: Taking stock. J Natl Cancer Inst 95:263-281, 2003
11. Ferrell B, Dow K, Grant M: Measurement of quality of life in cancer survivors. Qual Life Res 4:523-531, 1995
12. Gotay C, Muraoka M: Quality of life in long-term survivors of adult-onset cancers. J Natl Cancer Inst 90:656-667, 1998
13. Institute of Medicine: Improving Palliative Care for Cancer Patients. Washington DC, National Academy Press, 2001
14. Sepulveda C, Martin A, Yoshida T, et al: Palliative care: The World Health Organization's global perspective. J Pain Symptom Manage 24:91-96, 2002
15. Schipper H, Clinch J, McMurray A, et al: Measuring the quality of life of cancer patients: The Functional Living Index-Cancer-Development and validation. J Clin Oncol 2:472-483, 1984
16. Cella D, Tulsky D, Gray G, et al: The Functional Assessment of Cancer Therapy Scale: Development and validation of the general measure. J Clin Oncol 11:570-579, 1993
17. Sloan J, Sargent D, Mahoney M, et al: When less is more: The role of single item global QOL assessments in oncology clinical trials. Proc Int Soc Qual Life Res 7:593, 1998 (abstr)
18. Spitzer W, Dobson A, Hall J, et al: Measuring the quality of life of cancer patients: A concise QL-index for use by physicians. J Chronic Dis 34:585-597, 1981
19. Somerfield M: Hazards of quality-of-life data for clinical decision making. J Clin Oncol 21:82-83, 2003
20. Jatoi A, Kumar S, Sloan J, et al: On appetite and its loss. J Clin Oncol 18:2930-2932, 2000
21. Patrick DL, Ferketich SL, Frame PS, et al: National Institutes of Health State-of-the-Science Conference Statement: Symptom management in cancer-Pain, depression, and fatigue, July 15-17, 2002. J Natl Cancer Inst 95:1110-1117, 2003
22. Hickok J, Raubertas R, Hynes H, et al: Effect of an SSRI antidepressant on fatigue and depression in 738 cancer patients treated with chemotherapy: A URCC CCOP study. Proc Am Soc Clin Oncol 20:384a. 2001 (abstr 1531)
23. Sprangers M, Moinpour C, Moynihan T, et al: Assessing meaningful change in quality of life over time: A users' guide for clinicians. Mayo Clin Proc 77:561-571, 2002
24. Sloan J, Aaronson N, Cappelleir J, et al: Assessing the clinical significance of single items relative to summated scores. Mayo Clin Proc 77:479-487, 2002
25. Ganz P: Quality of life across the continuum of breast cancer care. Breast J 6:324-330, 2000
26. Guyatt G, Osoba D, Wu A, et al: Methods to explain the clinical significance of health status measures. Mayo Clin Proc 77:371-383, 2002